Partners

Biomay's R&D in innovative allergy therapeutics forms the hub of an extensive collaboration network in Austria. This network comprises two major universities, four public private partnership laboratories (Christian Doppler Laboratories) and well over 50 experienced scientists.

Allergy Research Network

Members of Biomay’s Allergy Network

Rudolf Valenta, MD
Professor for Allergology at the Medical University of Vienna,
Department of Pathophysiology / Division of Immunopathology,
Head of the CD Laboratory for Allergy Research, Research area: Immunopathology and vaccine development. He is the major force behing Biomay’s development product platform.

Fatima Ferreira, PhD
Associate Professor at the University of Salzburg,
Department of Molecular Biology / Division of Allergy and Immunology,
Head of the CD Laboratory for Allergy Diagnosis and Therapy,
Research area: Development of recombinant allergens for immunotherapy and diagnosis

Barbara Bohle, PhD
Professor at the Medical University of Vienna,
Department of Pathophysiology / Division of Immunopathology,
Head of the CD Laboratory for Immunomodulation,
Research area: Allergen-specific T cell responses and adjuvant development

Margarete Focke-Tejkl, PhD
Associate Professor at the Medical University of Vienna
Department of Pathophysiology / Division of Immunopathology,
CD Laboratory for Allergy Research,
Research area: B-cell epitope-based vaccine development 

Josef Thalhamer, PhD
Associate Professor at the University of Salzburg,
Department of Molecular Biology / Division of Allergy and Immunology,
CD Laboratory for Allergy Diagnosis and Therapy, Research area: Genetic immunization, protective and therapeutic RNA / DNA vaccines

Susanne Vrtala, PhD
Associate Professor at the Medical University of Vienna,
Department of Pathophysiology / Division of Immunopathology,
Head of the CD Laboratory for the Development of Allergen Chips, Research area: Diagnostic allergen micro-arrays 

To support the clinical development of its allergy vaccines, Biomay has assembled an Advisory Board of Key International Opinion Leaders in the field of allergy immunotherapy